Duan, Peng
Fisher, Jeffrey W.
Yoshida, Kenta
Zhang, Lei
Burckart, Gilbert J.
Wang, Jian
Funding for this research was provided by:
U.S. Food and Drug Administration
Article History
First Online: 6 September 2016
Compliance with Ethical Standards
:
: No external funding was used for this work or the preparation of the manuscript.
: Dr Kenta Yoshida was supported in part by an appointment to the Research Participation Program at the Center for Drug Evaluation and Research, administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the US Department of Energy and the US Food and Drug Administration (FDA).
: Peng Duan, Jeffery W. Fisher, Kenta Yoshida, Lei Zhang, Gilbert J. Burckart, and Jian Wang have no conflicts of interest that are directly relevant to the content of this manuscript.
: The contents of this manuscript reflect the views of the authors and should not be interpreted as representing the US FDA’s views or policies. No official support or endorsement by the FDA is intended or should be inferred. The mention of commercial products, their sources, or their use in connection with material reported herein is not to be construed as either an actual or implied endorsement of such products by the FDA.